 TEL AVIV, Israel and RALEIGH, NC , March 10, 2022 PRNewswire -- RedHill Biopharma Ltd. Nasdaq: RDHL RedHill or the Company, a specialty biopharmaceutical company, today announced that it will report its fourth quarter and full year 2021 financial results and operational highlights on Thursday, March 17, 2022. 